324
Views
0
CrossRef citations to date
0
Altmetric
Systematic Review

Understanding the Barriers and Enablers of Pharmacogenomic Testing in Primary Care: A Qualitative Systematic Review with Meta-Aggregation Synthesis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 135-154 | Received 14 Oct 2021, Accepted 16 Nov 2021, Published online: 16 Dec 2021

References

  • Caudle KT , KleinTE , HoffmanJMet al. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process. Curr. Drug Metab.15(2), 209–217 (2014).
  • Cecchin E , RoncatoR , GuchelaarHJ , ToffoliG. Ubiquitous Pharmacogenomics Consortium. Ubiquitous Pharmacogenomics (U-PGx): the time for implementation is now. An Horizon2020 Program to drive pharmacogenomics into clinical practice. Curr. Pharm. Biotechnol.18(3), 204–209 (2017).
  • Rollinson V , TurnerR , PirmohamedM. Pharmacogenomics for primary care: an overview. Genes11, 1337 (2020).
  • Dawes M . Pharmacogenetics in primary care. Healthcare Manag. Forum33(3), 97–101 (2020).
  • Verbelen M , WealeM , LewisC. Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?Pharmacogenomics J.17, 395–402 (2017).
  • Suppiah V , LimCX , HothamE. Community pharmacists and their role in pharmacogenomics testing: an Australian perspective drawing on international evidence. Aust. J. Primary Health24(6), 441–447 (2018).
  • Ewbank L , OmojomoloD , SullivanK , McKennaH. The rising cost of medicines to the NHS. What’s the story?The King’s Fund Briefing (2018). https://www.kingsfund.org.uk/sites/default/files/2018-04/Rising-cost-of-medicines.pdf
  • Bank PCD , SwenJJ , SchaapRDet al. A pilot study of the implementation of pharmacogenomic pharmacist initiated pre-emptive testing in primary care. Eur. J. Hum. Genet.27, 1532–1541 (2019).
  • Grice GR , SeatonTL , WoodlandAM , McLeodHL. Defining the opportunity for pharmacogenetic intervention in primary care. Pharmacogenomics7(1), 61–65 (2005).
  • Volpi S , BultCJ , ChisholmRLet al. Research directions in the clinical implementation of pharmacogenomics: an overview of US programs and projects. Clin. Pharmacol. Ther.103(5), 778–786 (2018).
  • Johnson JA . Pharmacogenetics in clinical practice: how far have we come and where are we going?Pharmacogenomics14(7), 835–843 (2013).
  • Klein ME , ParvezMM , ShinJG. Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. J. Pharm. Sci.106(9), 2368–2379 (2017).
  • Wang YT , MerlMY , YangJet al. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice. Pharmacogenomics J.20, 169–178 (2020).
  • Carroll JC , AllansonJ , MorrisonSet al. Informing integration of genomic medicine into primary care: an assessment of current practice, attitudes, and desired resources. Front. Genet.10, 1189 (2019).
  • Van der Wouden CH , Cambon-ThomsenA , CecchinEet al. Ubiquitous Pharmacogenomics Consortium. Implementing pharmacogenomics in Europe: design and implementation strategy of the Ubiquitous Pharmacogenomics Consortium. Clin. Pharmacol. Ther.101(3), 341–358 (2017).
  • Hippman C , NislowC. Pharmacogenomic testing: clinical evidence and implementation challenges. J. Pers. Med.9(3), 40 (2019).
  • Deverka PA , DoksumT , CarlsonRJ. Integrating molecular medicine into the US health-care system: opportunities, barriers, and policy challenges. Clin. Pharmacol. Ther.82(4), 427–434 (2007).
  • Haga SB . Integrating pharmacogenetic testing into primary care. Expert Rev. Precis. Med. Drug Dev.2(6), 327–336 (2017).
  • Relling MV , EvansWE. Pharmacogenomics in the clinic. Nature526(7573), 343–350 (2015).
  • Abbasi J . Getting pharmacogenomics into the clinic. JAMA316(15), 1533–1535 (2016).
  • Bell GC , CrewsKR , WilkinsonMRet al. Development and use of active clinical decision support for preemptive pharmacogenomics. J. Am. Med. Inform. Assoc.21(e1), e93–e99 (2014).
  • Hicks JK , StoweD , WillnerMAet al. Implementation of clinical pharmacogenomics within a large health system: from electronic health record decision support to consultation services. Pharmacotherapy36(8), 940–948 (2016).
  • Borden BA , GaleckiP , WellmannRet al. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenet. Genomics29(2), 31–38 (2019).
  • Ellingrod VL , MolineJ. Incorporating pharmacogenomics into practice. J. Pharm. Pract.20(3), 277–282 (2007).
  • Petit C , CroisetièreA , ChenF , LaverdièreI. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice. Pharmacogenomics21(4), 247–256 (2020).
  • Yau A , HusainRB , HaqueM. Systematic review of knowledge, attitude and practice towards pharmacogenomics among doctors. Int. J. Pharmaceut. Res.7(1), Jan–Mar (2015).
  • O’Brien TJ , LeLacheurS , WardC , LeeNH , CallierS , HarralsonAF. Impact of a personal CYP2D6 testing workshop on physician assistant student attitudes toward pharmacogenetics. Pharmacogenomics17(4), 341–352 (2016)
  • Mikat-Stevens NA , LarsonIA , TariniBA. Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature. Genet. Med.17(3), 169–176 (2015).
  • Suther S , GoodsonP. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med.5(2), 70–76 (2003).
  • Hayward J , McDermottJ , QureshiN , NewmanW. Pharmacogenomic testing to support prescribing in primary care: a structured review of implementation models. Pharmacogenomics22(12), 761–776 (2021).
  • Yau A , AzizABA , HaqueM. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J. Young Pharmacists7(3), Jul–Sep (2015).
  • Tong A , FlemmingK , McInnesEet al. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med. Res. Methodol.12, 181 (2012).
  • Critical appraisal skills programme. CASP (Qualitative) Checklist (2018). http://casp-uk.net
  • Cane J , O’ConnorD , MichieS. Validation of the theoretical domains framework for use in behavior change and implementation research. Implementation Sci.7, 37 (2012).
  • Atkins L , FrancisJ , IslamRet al. A guide to using the Theoretical Domains Framework of behavior change to investigate implementation problems. Implementation Sci.12, 77 (2017).
  • Joanna Briggs Institute . Critical appraisal tools. https://jbi.global/critical-appraisal-tools
  • Munn Z , PorrittK , LockwoodC , AromatarisE , PearsonA. Establishing confidence in the output of qualitative research synthesis: the ConQual approach. BMC Med. Res. Methodol.14, 108 (2014).
  • Park ER , KleimannS , PelanJA , ShieldsAE. Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians. Nicotine Tob. Res.9(2), 271–279 (2007).
  • Dressler LG , BellGC , AbernathyPM , RuchK , DenslowS. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study. Pharmacogenomics20(6), 433–446 (2019).
  • Williams EC , YoungJP , AchtmeyerCE , HendershotCS. Primary care providers’ interest in using a genetic test to guide alcohol use disorder treatment. J. Substance Abuse Treat.70, 14–20 (2016).
  • Lemke AA , HuttenSelkirk CG , GlaserNSet al. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Per. Med.14(5), 389–400 (2017).
  • Frigon MP , BlackburnMÈ , Dubois-BouchardC , GagnonAL , TardifS , TremblayK. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients. Pharmacogenomics20(8), 589–598 (2019).
  • Carroll JC , MakuwazaT , MancaDPet al. Primary care providers’ experiences with and perceptions of personalized genomic medicine. Can. Fam. Physician62(10), e626–e635 (2016).
  • Chase DA , BaronS , AshJS. Clinical decision support and primary care acceptance of genomic medicine. Stud. Health Technol. Inform.245, 700–703 (2017).
  • Unertl KM , JaffaH , FieldJR , PriceL , PetersonJF. Clinician perspectives on using pharmacogenomics in clinical practice. Per. Med.12(4), 339–347 (2015).
  • Haga SB , TindallG , O’DanielJM. Professional perspectives about pharmacogenetic testing and managing ancillary findings. Genet. Test Mol. Biomarkers16(1), 21–24 (2012).
  • Harding B , WebberC , RuhlandLet al. Primary care providers’ lived experiences of genetics in practice. J. Community Genet.10(1), 85–93 (2019).
  • Lee YM , McKillipRP , BordenBA , KlammerCE , RatainMJ , O’DonnellPH. Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenet. Genomics27(5), 179–189 (2017).
  • Rafi I , CrinsonI , DawesM , RafiD , PirmohamedM , WalterFM. The implementation of pharmacogenomics into UK general practice: a qualitative study exploring barriers, challenges and opportunities. J. Commun. Genet.11(3), 269–277 (2020).
  • Rigter T , JansenME , de GrootJM , JanssenSWJ , RodenburgW , CornelMC. Implementation of pharmacogenetics in primary care: a multi-stakeholder perspective. Front. Genet.11, 10 (2020).
  • Barr M , RoseD. The great ambivalence: factors likely to affect service user and public acceptability of the pharmacogenomics of antidepressant medication. Social Health Illn.30(6), 944–958 (2008).
  • Issa AM , TufailW , HutchinsonJ , TenorioJ , BaligaMP. Assessing patient readiness for the clinical adoption of personalized medicine. Public Health Genomics12(3), 163–169 (2009).
  • De Marco M , CykertS , CoadNet al. Views on personalized medicine: do the attitudes of African American and white prescription drug consumers differ? Public Health Genomics 13(5), 276–283 (2010).
  • Haddy CA , WardHM , AngleyMT , McKinnonRA. Consumers’ views of pharmacogenetics – a qualitative study. Res. Social Adm. Pharm.6(3), 221–231 (2010).
  • Van der Wouden CH , PaasmanE , TeichertM , CroneMR , GuchelaarHJ , SwenJJ. Assessing the implementation of pharmacogenomic panel-testing in primary care in the Netherlands utilizing a theoretical framework. J. Clin. Med.9(3), 814 (2020).
  • Haga SB . First responder to genomic information: a guide for primary care providers. Mol. Diagn. Ther.23(4), 459–466 (2019).
  • Thomas J , HardenA. Methods for the thematic synthesis of qualitative research in systematic reviews. BMC Med. Res. Methodol.8, 45 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.